Transforming growth factor β signaling pathway: A promising therapeutic target for cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Transforming growth factor β signaling pathway: A promising therapeutic target for cancer
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-07-23
DOI
10.1002/jcp.29108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors
- (2018) Julius Strauss et al. CLINICAL CANCER RESEARCH
- The clinical and biological roles of transforming growth factor beta in colon cancer stem cells: A systematic review
- (2018) Anna Chruścik et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Polymeric Nano-Micelles as Novel Cargo-Carriers for LY2157299 Liver Cancer Cells Delivery
- (2018) Nemany Hanafy et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
- (2018) Daniele V. F. Tauriello et al. NATURE
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- LY2157299 Monohydrate, a TGF-βR1 Inhibitor, Suppresses Tumor Growth and Ascites Development in Ovarian Cancer
- (2018) Qing Zhang et al. Cancers
- Effects of microRNA-370 on mesangial cell proliferation and extracellular matrix accumulation by binding to canopy 1 in a rat model of diabetic nephropathy
- (2018) Feng-Na Yu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Thrombospondin-4 mediates TGF-β-induced angiogenesis
- (2017) S Muppala et al. ONCOGENE
- Pharmacological and immunological targeting of tumor mesenchymalization
- (2017) Justin M. David et al. PHARMACOLOGY & THERAPEUTICS
- Inhibition of angiogenesis by arsenic trioxide via TSP-1–TGF-β1-CTGF–VEGF functional module in rheumatoid arthritis
- (2017) Juan Zhang et al. Oncotarget
- Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma
- (2016) M. Simonelli et al. ANNALS OF ONCOLOGY
- Dichotomous roles of TGF-β in human cancer
- (2016) Jennifer J. Huang et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- The TGFβ pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels
- (2016) Elisenda Alsina-Sanchis et al. INTERNATIONAL JOURNAL OF CANCER
- A Phase II Study of PF-03446962 in Patients with Advanced Malignant Pleural Mesothelioma. CCTG Trial IND.207
- (2016) Paul Wheatley-Price et al. Journal of Thoracic Oncology
- The Discovery and Early Days of TGF-β: A Historical Perspective
- (2016) Harold L. Moses et al. Cold Spring Harbor Perspectives in Biology
- Novel TGF-β inhibitors ready for prime time in onco-immunology
- (2016) Armand de Gramont et al. OncoImmunology
- The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone
- (2015) Pierrick G.J. Fournier et al. CANCER CELL
- A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer
- (2015) G. Giaccone et al. EUROPEAN JOURNAL OF CANCER
- TGF-β/Smad2/3 signal pathway involves in U251 cell proliferation and apoptosis
- (2015) Hong-wei Zhao et al. GENE
- TGF- Antibody Uptake in Recurrent High-Grade Glioma Imaged with 89Zr-Fresolimumab PET
- (2015) M. W. den Hollander et al. JOURNAL OF NUCLEAR MEDICINE
- TGF-β and EGF induced HLA-I downregulation is associated with epithelial-mesenchymal transition (EMT) through upregulation of snail in prostate cancer cells
- (2015) Xiao-Hui Chen et al. MOLECULAR IMMUNOLOGY
- Stromal gene expression defines poor-prognosis subtypes in colorectal cancer
- (2015) Alexandre Calon et al. NATURE GENETICS
- TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis
- (2015) M-F Pang et al. ONCOGENE
- Tumor-Derived Transforming Growth Factor-β is Critical for Tumor Progression and Evasion from Immune Surveillance
- (2014) Zheng Li et al. Asian Pacific Journal of Cancer Prevention
- Inhibition of transforming growth factor beta/SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancer
- (2014) Hui Ji et al. CANCER SCIENCE
- First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma
- (2014) Jordi Rodon et al. CLINICAL CANCER RESEARCH
- Overexpression of Smad7 Blocks Primary Tumor Growth and Lung Metastasis Development in Osteosarcoma
- (2014) A. Lamora et al. CLINICAL CANCER RESEARCH
- TGF-beta Signaling in Cancer Treatment
- (2014) Isabel Fabregat et al. CURRENT PHARMACEUTICAL DESIGN
- O126 EVALUATION OF LY2157299 MONOHYDRATE (LY), A TGF-β RECEPTOR I KINASE INHIBITOR, IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: PHASE 2 STUDY RESULTS OF SAFETY, EFFICACY AND PK/PD
- (2014) G. Giannelli et al. JOURNAL OF HEPATOLOGY
- TGF- : Duality of Function Between Tumor Prevention and Carcinogenesis
- (2014) D. R. Principe et al. JNCI-Journal of the National Cancer Institute
- miR-181a mediates TGF-β-induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer
- (2014) Jennifer Brockhausen et al. LIVER INTERNATIONAL
- Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
- (2014) John C. Morris et al. PLoS One
- Snail and Slug, key regulators of TGF-β-induced EMT, are sufficient for the induction of single-cell invasion
- (2013) Hildegonda P.H. Naber et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- TGF-β-Smad2 dependent activation of CDC 25A plays an important role in cell proliferation through NFAT activation in metastatic breast cancer cells
- (2013) Suman Sengupta et al. CELLULAR SIGNALLING
- Functions of TGF-β-Exposed Plasmacytoid Dendritic Cells
- (2013) Philippe Saas et al. CRITICAL REVIEWS IN IMMUNOLOGY
- Targeting TGF-β signaling in cancer
- (2013) Lior H Katz et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients
- (2013) James P Stevenson et al. OncoImmunology
- Cervical cancer cells induce apoptosis in TCD4+ lymphocytes through the secretion of TGF-β
- (2012) Hugo López-Muñoz et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- TGF-β as a therapeutic target in high grade gliomas – Promises and challenges
- (2012) Justin V. Joseph et al. BIOCHEMICAL PHARMACOLOGY
- TGF- β1–mediated Apoptosis Associated With SMAD-dependent MitochondrialBcl-2 Expression
- (2012) Masoomeh Bakhshayesh et al. Clinical Lymphoma Myeloma & Leukemia
- Targeting the TGFβ signalling pathway in disease
- (2012) Rosemary J. Akhurst et al. NATURE REVIEWS DRUG DISCOVERY
- Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth
- (2011) Xinhai Wan et al. BONE
- Outgrowth of Drug-Resistant Carcinomas Expressing Markers of Tumor Aggression after Long-term T RI/II Kinase Inhibition with LY2109761
- (2011) E. C. Connolly et al. CANCER RESEARCH
- Blockade of TGF- Signaling by the TGF R-I Kinase Inhibitor LY2109761 Enhances Radiation Response and Prolongs Survival in Glioblastoma
- (2011) M. Zhang et al. CANCER RESEARCH
- Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer
- (2011) Karl-Hermann Schlingensiepen et al. CANCER SCIENCE
- 1203 ORAL Long-term Survival in a Phase II Study of Belagenpumatucel-L (TGF-β Antisense Modified Tumour Cell Vaccine) in Non-small Cell Lung Cancer (NSCLC)
- (2011) E. Juhasz et al. EUROPEAN JOURNAL OF CANCER
- An update on transforming growth factor-β (TGF-β): Sources, types, functions and clinical applicability for cartilage/bone healing
- (2011) A. S. Patil et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Overexpression of miR-370 and downregulation of its novel target TGFβ-RII contribute to the progression of gastric carcinoma
- (2011) S-S Lo et al. ONCOGENE
- The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis
- (2011) Takeshi Imamura et al. Breast Cancer
- Inhibitory effect of a TGFβ receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells
- (2010) O Shinto et al. BRITISH JOURNAL OF CANCER
- Transcriptional crosstalk between TGFβ and stem cell pathways in tumor cell invasion: Role of EMT promoting Smad complexes
- (2010) Jonas Fuxe et al. CELL CYCLE
- Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis
- (2010) Vidya Ganapathy et al. Molecular Cancer
- Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study
- (2010) U. Bogdahn et al. NEURO-ONCOLOGY
- Transforming Growth Factor- 2 Is a Molecular Determinant for Site-Specific Melanoma Metastasis in the Brain
- (2009) C. Zhang et al. CANCER RESEARCH
- The type III TGF-β receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-β signaling
- (2009) Jason D. Lee et al. CARCINOGENESIS
- Antimetastatic Role of Smad4 Signaling in Colorectal Cancer
- (2009) Bixiang Zhang et al. GASTROENTEROLOGY
- Transforming growth factor-beta 1 (TGF-β1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis
- (2009) Giovanni Ferrari et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The type III TGF- receptor regulates epithelial and cancer cell migration through -arrestin2-mediated activation of Cdc42
- (2009) K. Mythreye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of Tumor Immune Surveillance and Tumor Immune Subversion by TGF-β
- (2009) Hae-Young Park et al. Immune Network
- Transforming growth factor-β signaling: emerging stem cell target in metastatic breast cancer?
- (2008) Antoinette R. Tan et al. BREAST CANCER RESEARCH AND TREATMENT
- An Anti-Transforming Growth Factor Antibody Suppresses Metastasis via Cooperative Effects on Multiple Cell Compartments
- (2008) J.-S. Nam et al. CANCER RESEARCH
- LY2109761, a novel transforming growth factor receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
- (2008) D. Melisi et al. MOLECULAR CANCER THERAPEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started